Bioactive micropatterned platform to engineer myotube-like cells from stem cells.
Ajay TijoreBae Hoon LeeHari Krishna Salila Vijayalal MohanHolden LiLay Poh TanPublished in: Biofabrication (2020)
Skeletal muscle has the capacity to repair and heal itself after injury. However, this self-healing ability is diminished in the event of severe injuries and myopathies. In such conditions, stem cell-based regenerative treatments can play an important part in post injury restoration. We herein report the development of a bioactive (integrin-β1 antibody immobilized) gold micropatterned platform to promote human mesenchymal stem cells (hMSCs) differentiation into the myotube-like cells. hMSCs grown on bioactive micropattern differentiated into the myotube-like cells within two weeks. Further, up-regulation of myogenic markers, multi-nucleated state with continuous actin cytoskeleton and absence of proliferation marker confirmed the formation of myotube-like cells on bioactive micropattern. Prominent expression of elongated integrin-β1 focal adhesions (ITG-β1 FAs) and development of anisotropic stress fibres in those differentiated cells elucidated their importance in stem cell myogenesis. Together these findings delineate the synergistic role of engineered cell anisotropy and ITG-β1 mediated signaling in the development of myotube-like cells from hMSCs.
Keyphrases
- stem cells
- skeletal muscle
- cell therapy
- mesenchymal stem cells
- endothelial cells
- induced apoptosis
- high throughput
- single cell
- signaling pathway
- poor prognosis
- type diabetes
- cell migration
- metabolic syndrome
- tissue engineering
- bone marrow
- long non coding rna
- oxidative stress
- drug delivery
- cancer therapy
- drug induced
- pluripotent stem cells